Mobidiag Gains CE-IVD Mark for Sepsis Test | GenomeWeb
NEW YORK (GenomeWeb News) - Mobidiag, a Helsinki, Finland-based biotechnology firm, this week said that its Prove-it array-based in vitro diagnostic for sepsis has met the requirements for CE-IVD marking and can now be marketed to clinicians in Europe.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.